Iacovelli, Roberto
Ciccarese, Chiara
Facchini, Gaetano
Milella, Michele
Urbano, Federica
Basso, Umberto
De Giorgi, Ugo
Sabbatini, Roberto
Santini, Daniele
Berardi, Rossana
Santoni, Matteo
Bracarda, Sergio
Massari, Francesco
Masini, Cristina
De Tursi, Michele
Ricotta, Riccardo
Buti, Sebastiano
Zustovich, Fable
Sepe, Pierangela
Rossetti, Sabrina
Maruzzo, Marco
Cortesi, Enrico
Tortora, Giampaolo
Procopio, Giuseppe
Article History
First Online: 15 July 2020
Change Date: 28 August 2020
Change Type: Correction
Change Details: While typesetting the article the Table 3 column/row entries are interchanged. Please find below the updated Table
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this article.
: R. Iacovelli served as consultant for Ipsen; Pfizer; Novartis; BMS, MSD, Janssen. G. Procopio served as consultant for Bayer, BMS, Ipsen, Janssen, MSD, Novartis, Pfizer. Conflict of interest/Competing interests: Roberto Iacovelli served as consultant for Ipsen; Pfizer; Novartis; BMS, MSD, Janssen. Giuseppe Procopio served as consultant for Bayer, BMS, Ipsen, Janssen, MSD, Novartis, Pfizer. Chiara Ciccarese, Gaetano Facchini, Michele Milella, Federica Urbano, Umberto Basso, Ugo De Giorgi, Roberto Sabbatini, Daniele Santini, Rossana Berardi, Matteo Santoni, Sergio Bracarda, Francesco Massari, Cristina Masini, Michele De Tursi, Riccardo Ricotta, Sebastiano Buti, Fable Zustovich, Pierangela Sepe, Sabrina Rossetti, Marco Maruzzo, Enrico Cortesi, and Giampaolo Tortora declare that they have no conflicts of interest that might be relevant to the contents of this article.